Shizuoka Cancer Center

Shizuoka, Shizuoka 411-8777

1 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Merkel Cell, RET-altered Non Small Cell Lung Cancer, RET-altered Solid Tumors

Studies at this site

• Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities — Recruiting now
• Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200) — Completed